Data from The Insulin-like Growth Factor-1 Receptor–Targeting Antibody, CP-751,871, Suppresses Tumor-Derived VEGF and Synergizes with Rapamycin in Models of Childhood Sarcoma
Open Access
- 30 March 2023
- other
- Published by American Association for Cancer Research (AACR)